An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine

Cancer Gene Therapy (2011) - Comments
pubmed: 21836633 doi: 10.1038/cgt.2011.45 issn: 1476-5500 issn: 0929-1903

M Bhattacharyya, J Francis, A Eddouadi, N R Lemoine, G Halldén